Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020 Feb 19;: Authors: Gao J, Tian Z, Yang X Abstract The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future. PMID: 32074550 [PubMed - as supplied by publisher]
Even as new and faster tests become available, lengthy delays to obtain results continue and test materials are running low, compounding the crises hospitals are facing.
Arkansas' governor on Tuesday opposed allowing cities to issue their own stay-at-home orders during the coronavirus outbreak while the state resists such a restriction.
Publication date: Available online 6 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Dawn M. Angel, Robert S. Zeiger, Scott H. Sicherer, David A. Khan, Michael Schatz
Publication date: Available online 3 April 2020Source: Autoimmunity ReviewsAuthor(s): Dennis McGonagle, Kassem Sharif, Anthony O'Regan, Charlie Bridgewood
After planning for staffing and patient management at his institution, oncologist Don Dizon reflects on his personal risk in managing COVID-19-positive patients.Medscape Oncology
No abstract available
Jeffrey Miron andErin PartinSome immigration opponents want lawmakers tocancel the H1B visa lottery, which admits 85,000 skilled immigrants per year. Their position may reflect a belief that high ‐skilled immigration is especially dangerous during the COVID-19 pandemic. If so, they have the analysis backwards.Not only do highly skilled immigrants help U.S. companies develop new technologies and innovations; many serve on the front lines of the medical response to COVID-19.Medical professionals make up roughly5 percent of H1B visa applicants out of the top 100 occupations. These doctors, nurses, and technicia...
Purpose of review One of the defining trends of population movement in the last half century has been global urbanization. Depression is the most common mental disorder in the world, but it is unclear how urbanization and urban living affect depression outcomes. Grounded in a previously articulated conceptual framework, we systematically reviewed recently published studies on urbanization, urbanicity, and depression. Recent findings Eleven articles were included in this review. Four studies found that living in urban areas was associated with elevated odds or more symptoms of depression. Three studies – all done...
A group of moderately ill people were given hydroxychloroquine, which appeared to ease their symptoms quickly, but more research is needed.
After President Trump, late last week, expressed great confidence in the promise of a new COVID-19 therapy that combines two existing prescription medications, supplies of these two drugs rapidly began disappearing from pharmacy shelves. The U.S. Food and Drug Administration allowed an Indian company previously restricted from importing drug products into the US to now start manufacturing one of the drugs. And U.S. plants began gearing up to produce enough to meet the surge in demand. But in those few days, a few people who began self medicating with the drugs in an effort to prevent COVID-19 have died, and others have bee...